Literature DB >> 15949119

The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial.

Antonio Federici1, Paolo Giorgi Rossi, Piero Borgia, Francesco Bartolozzi, Sara Farchi, Gabriella Gausticchi.   

Abstract

INTRODUCTION: We conducted a cluster-randomized trial aimed at assessing the effect of the type of faecal occult blood, guaiac or immunochemical test on screening compliance.
METHODS: We sampled 130 general practitioners (GPs) who consented to participate in the trial. We randomly allocated half of them to the guaiac (Hemo-Fec) and half to the immunochemical test (OC-Hemodia). We sampled 2/10 of the GPs' 50-75-year-old patients (n=7332) and randomly divided this population into half. One half was invited to be screened at the GP's office and the other to the nearest gastroenterology ward. The principal outcome was the percentage of returned tests.
RESULTS: The immunochemical test had a compliance of 35.8% and the guaiac of 30.4% (relative risk [RR] 1.20; 95% confidence interval [CI] 1.02-1.44). The difference was mostly due to a higher probability of returning the sample: 93.8% and 88.6% for immunochemical and guaiac, respectively (RR 1.06; 95% CI 1.02-1.10). The guaiac test had a higher prevalence of positives (10.3% versus 6.3%, RR 0.603; 95% CI 0.433-0.837). There was a higher variability in the results obtained with the guaiac test compared with the immunochemical (F[1, 12] = 16.25; P=0.0017).
CONCLUSIONS: Compliance is more likely with the immunochemical than the guaiac test, independent of the provider. Guaiac tests show a higher variability of the results among centres. The successful implementation of a screening programme requires a period of standardization of the test reading in order to avoid unexpected work overload for colonoscopy services.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15949119     DOI: 10.1258/0969141053908357

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  31 in total

Review 1.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 2.  Faecal occult blood testing for colorectal cancer screening: the past or the future.

Authors:  Sally C Benton; Helen E Seaman; Stephen P Halloran
Journal:  Curr Gastroenterol Rep       Date:  2015-02

3.  Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-09-01

4.  Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.

Authors:  L Guittet; V Bouvier; N Mariotte; J P Vallee; D Arsène; S Boutreux; J Tichet; G Launoy
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

5.  Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.

Authors:  Grace Clarke Hillyer; Karen M Schmitt; Daniel E Freedberg; Rachel A Kramer; Yin Su; Richard M Rosenberg; Alfred I Neugut
Journal:  Am J Prev Med       Date:  2014-06-17       Impact factor: 5.043

6.  Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial.

Authors:  Cédric Rat; Corinne Pogu; Delphine Le Donné; Chloé Latour; Gaelle Bianco; France Nanin; Anne Cowppli-Bony; Aurélie Gaultier; Jean-Michel Nguyen
Journal:  JAMA       Date:  2017-09-05       Impact factor: 56.272

7.  Adherence to repeat fecal occult blood testing in an urban community health center network.

Authors:  David T Liss; Anita Petit-Homme; Joe Feinglass; David R Buchanan; David W Baker
Journal:  J Community Health       Date:  2013-10

Review 8.  Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Douglas J Robertson; Jeffrey K Lee; C Richard Boland; Jason A Dominitz; Francis M Giardiello; David A Johnson; Tonya Kaltenbach; David Lieberman; Theodore R Levin; Douglas K Rex
Journal:  Am J Gastroenterol       Date:  2016-10-18       Impact factor: 10.864

Review 9.  CT colonography for population screening of colorectal cancer: hints from European trials.

Authors:  Lapo Sali; Daniele Regge
Journal:  Br J Radiol       Date:  2016-09-14       Impact factor: 3.039

10.  Uptake in cancer screening programmes: a priority in cancer control.

Authors:  D P Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.